These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16292235)

  • 21. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [PICS: pharmaceutical inspection cooperation scheme].
    Morénas J
    Ann Pharm Fr; 2009 Jan; 67(1):16-9. PubMed ID: 19152846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 25. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2011; (961):1-428, back cover. PubMed ID: 21699061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Masters of efficiency.
    Hoag H
    Nature; 2006 Sep; 443(7107):116-7. PubMed ID: 17001767
    [No Abstract]   [Full Text] [Related]  

  • 28. Good Manufacturing Practice for Medicinal Products in Bulgaria: an Analysis of Regulatory Inspection Findings.
    Stoimenova AH; Kirilov BJ; Gueorguiev SR; Petkova-Gueorguieva ES; Ognianov SG
    Folia Med (Plovdiv); 2020 Mar; 62(1):165-171. PubMed ID: 32337904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical computer validation for pharmaceutical laboratories.
    McDowall RD
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):13-22. PubMed ID: 8833962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brazilian National System for the Monitoring and Improvement of Compounding Practices: program outcomes.
    de Souza HG; Favaro A; Andrade AL; Gomes LY; Garcez Mdo C
    Int J Pharm Compd; 2012; 16(2):98-102. PubMed ID: 23050320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of total quality principles to achieve regulatory compliance in research laboratories.
    Hynes MD
    Qual Assur; 1995 Mar; 4(1):34-40. PubMed ID: 8520863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in larger plants].
    Büchler W
    Pharm Acta Helv; 1973 Jan; 48(1):11-21. PubMed ID: 4696261
    [No Abstract]   [Full Text] [Related]  

  • 35. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quality control in the pharmaceutical industry].
    Sloot HA
    Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061
    [No Abstract]   [Full Text] [Related]  

  • 37. The 1941 sulfathiazole disaster and the birth of good manufacturing practices.
    Swann JP
    PDA J Pharm Sci Technol; 1999; 53(3):148-53. PubMed ID: 10754705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating inspection practices of pharmaceutical manufacturing facilities in selected Arab countries: views of inspectors and pharmaceutical industry employees.
    Garg S; Hasan R; Scahill S; Babar ZU
    East Mediterr Health J; 2013 Nov; 19(11):919-29. PubMed ID: 24673082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiencies of product labeling directions for the preparation of radiopharmaceuticals.
    Hung JC; Ponto JA; Gadient KR; Frie JA; Aksamit CM; Enquist CL; Carrels KE
    J Am Pharm Assoc (2003); 2004; 44(1):30-5. PubMed ID: 14965150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Process analytical technology (PAT) for biopharmaceutical products.
    Rathore AS; Bhambure R; Ghare V
    Anal Bioanal Chem; 2010 Sep; 398(1):137-54. PubMed ID: 20480150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.